Fleur Jeffries - PharmaTimes

Multi-million-pound funding for genomics research

Vital financing will help boost diagnosis, treatment and prospects of patient groups

Study uses carious drug combinations to increase survival among lung cancer patients

Therapy treats patients with metastatic non-small cell lung cancer and has completed successful phase 3 trial

ACD856 has also been shown across preclinical studies to improve cognition and memory

A final decision for daprodustat by the FDA is expected by 1 February 2023